118 related articles for article (PubMed ID: 38583080)
1. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer.
Abaza MS; Orabi KY; Al-Quattan E; Al-Attiyah RJ
Cancer Cell Int; 2015; 15():46. PubMed ID: 26074733
[TBL] [Abstract][Full Text] [Related]
3. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway.
Bao L; Liu F; Guo HB; Li Y; Tan BB; Zhang WX; Peng YH
Tumour Biol; 2016 Aug; 37(8):11365-74. PubMed ID: 26960693
[TBL] [Abstract][Full Text] [Related]
4. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
5. A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.
Kandhavelu J; Subramanian K; Naidoo V; Sebastianelli G; Doan P; Konda Mani S; Yapislar H; Haciosmanoglu E; Arslan L; Ozer S; Thiyagarajan R; Candeias NR; Penny C; Kandhavelu M; Murugesan A
Br J Pharmacol; 2024 Jan; 181(1):107-124. PubMed ID: 37183661
[TBL] [Abstract][Full Text] [Related]
6. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study.
Tantawy MA; El-Sherbeeny NA; Helmi N; Alazragi R; Salem N; Elaidy SM
Mol Cell Biochem; 2020 Jun; 469(1-2):143-157. PubMed ID: 32356241
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
8. Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERRα/VEGF/KDR signaling pathway.
Li Q; Wang Y; Zhang L; Chen L; Du Y; Ye T; Shi X
Fitoterapia; 2016 Jun; 111():78-86. PubMed ID: 27105956
[TBL] [Abstract][Full Text] [Related]
9. Baicalein Inhibits Proliferation Activity of Human Colorectal Cancer Cells HCT116 Through Downregulation of Ezrin.
Chen Z; Hou R; Gao S; Song D; Feng Y
Cell Physiol Biochem; 2018; 49(5):2035-2046. PubMed ID: 30244250
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
12. Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells.
Song HM; Park GH; Eo HJ; Lee JW; Kim MK; Lee JR; Lee MH; Koo JS; Jeong JB
Biomol Ther (Seoul); 2015 Jul; 23(4):339-44. PubMed ID: 26157550
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
14. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
Wang Y; Liu X; Liu J; Zhang T
Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
[No Abstract] [Full Text] [Related]
16. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
[TBL] [Abstract][Full Text] [Related]
18. Monotropein Induced Apoptosis and Suppressed Cell Cycle Progression in Colorectal Cancer Cells.
Gao Q; Li L; Zhang QM; Sheng QS; Zhang JL; Jin LJ; Shang RY
Chin J Integr Med; 2024 Jan; 30(1):25-33. PubMed ID: 37750986
[TBL] [Abstract][Full Text] [Related]
19. Naringenin prevents ischaemic stroke damage via anti-apoptotic and anti-oxidant effects.
Wang K; Chen Z; Huang J; Huang L; Luo N; Liang X; Liang M; Xie W
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):862-871. PubMed ID: 28453191
[TBL] [Abstract][Full Text] [Related]
20. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
